2 recruiting, 1 completed, 1 unknown. 2 Phase 2, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Guanosine Diphosphate: new trials by email Literature Review of Guanosine Diphosphate trials Research Report on Guanosine Diphosphate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma Etoposide, Cytarabine, PEG-rhG-CSF - Non-Hodgkin's Lymphoma, Hematopoietic Stem Cell Mobilization | Phase 3 | Recruiting | The Affiliated People's Hospital of Ningbo University | 99 | 2024-08-01 | 2025-12-04 |
| Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma AutoSCT OR CAR T-cell Therapy, GDP, Epcoritamab - Large Cell Lymphoma, Diffuse, Relapsed Cancer | Phase 2 | Recruiting | Dipenkumar Modi | 35 | 2023-10-31 | 2026-07-10 |
| To Observe the Psychophysiological Alterations in Traumatic Stress Subjects GDP - Traumatic Stress, Post-Traumatic Growth | Not applicable | Completed | University of Karachi | 246 | 2019-12-02 | 2021-08-11 |
| Endostar Aggressive Treatment of Peripheral T-cell Lymphoma (PTCL) Phase II Clinical Study GDP, Endostar - Peripheral T-cell Lymphomas | Phase 2 | Unknown | Nanjing NingQi Medicine Science and Technology Co., Ltd. | 60 | 2014-12-01 | 2015-08-11 |
Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Non-Hodgkin (1) · Lymphoma, T-Cell, Peripheral (1) · Neoplasms (1) · Recurrence (1)
Dipenkumar Modi (1) · Nanjing NingQi Medicine Science and Technology Co., Ltd. (1) · The Affiliated People's Hospital of Ningbo University (1) · University of Karachi (1)
China (2) · Pakistan (1) · United States (1)
Dipenkumar Modi, MD (1) · Peipei Ye (1)